de

Registrieren
Investieren birgt Risiken und ist nicht für alle Anleger geeignet.

MC

609.7

+1.84%↑

ALV

302.5

+0.27%↑

SAF

214.4

+2.49%↑

BBVA

9.088

-2.36%↓

BN

65.16

-0.24%↓

MC

609.7

+1.84%↑

ALV

302.5

+0.27%↑

SAF

214.4

+2.49%↑

BBVA

9.088

-2.36%↓

BN

65.16

-0.24%↓

MC

609.7

+1.84%↑

ALV

302.5

+0.27%↑

SAF

214.4

+2.49%↑

BBVA

9.088

-2.36%↓

BN

65.16

-0.24%↓

MC

609.7

+1.84%↑

ALV

302.5

+0.27%↑

SAF

214.4

+2.49%↑

BBVA

9.088

-2.36%↓

BN

65.16

-0.24%↓

MC

609.7

+1.84%↑

ALV

302.5

+0.27%↑

SAF

214.4

+2.49%↑

BBVA

9.088

-2.36%↓

BN

65.16

-0.24%↓

Home・Aktien・Bayer AG
Search

Bayer AG

Geschlossen

Branche Finanzen

26.465 -0.32

Neutral

Kursupdate 17. Okt. 2024, 15:29 UTC

BuySell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

26.25

Max

26.56

Schlüsselkennzahlen

By Trading Economics

Einkommen

-2B

-34M

Verkäufe

-2.6B

11B

KGV

Branchendurchschnitt

30.9

17.821

EPS

0.94

Gewinnspanne

-0.305

EBITDA

-2.6B

1.7B

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+13.97 upside

Dividenden

By Dow Jones

Nächstes Ergebnis

12. Nov. 2024

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-3.7B

26B

Vorheriger Eröffnungskurs

26.79

Vorheriger Schlusskurs

26.465

Nachrichtenstimmung

By Acuity

33%

67%

128 / 461 Ranking in Finance

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

26.13 / 26.685 Unterstützung & Widerstand

Bayer AG Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

9. Okt. 2024, 17:03 UTC

Wichtige Markttreiber

Bayer Shares Plunge After U.S. Legal Setback -- Update

DJ

Lesen

9. Okt. 2024, 14:21 UTC

Wichtige Markttreiber

Bayer Shares Plunge After U.S. Legal Setback

DJ

Lesen

16. Aug. 2024, 08:28 UTC

Wichtige Markttreiber

Bayer Shares Surge After Appeal Win in Roundup Cancer Suit

DJ

Lesen

15. Aug. 2024, 21:43 UTC

Ergebnisse

Bayer's Monsanto Wins Appeal in Roundup Cancer Suit

DJ

Lesen

6. Aug. 2024, 10:56 UTC

Ergebnisse

Bayer Posts Net Loss as Tough Agriculture Market Bites -- Update

DJ

Lesen

6. Aug. 2024, 09:00 UTC

Ergebnisse

Correction to Bayer Article

DJ

Lesen

6. Aug. 2024, 06:29 UTC

Ergebnisse

Bayer Posts Net Loss, Dragged by Weaker Crop-Science Performance

DJ

Lesen

14. Mai 2024, 13:21 UTC

Ergebnisse

Bayer Plans More Job Cuts in Push for Fewer Bosses -- Update

DJ

Lesen

23. Aug. 2024, 08:51 UTC

Market Talk

BMW's EV Coup Over Tesla in Europe Shows Strength as Tesla Products Age -- Market Talk

DJ

Lesen

16. Aug. 2024, 14:21 UTC

Market Talk

Bayer's Appeal Win Could Be First Step to End Roundup Litigation -- Market Talk

DJ

Lesen

16. Aug. 2024, 08:58 UTC

Ergebnisse
Heiße Aktien

Stocks to Watch Friday: Applied Materials, H&R Block, Bayer, Bavarian Nordic -- WSJ

DJ

Lesen

6. Aug. 2024, 10:47 UTC

Market Talk

Bayer Could Face Consensus Earnings Downgrades Amid Currency Headwinds -- Market Talk

DJ

Lesen

6. Aug. 2024, 08:55 UTC

Market Talk
Ergebnisse

Bayer's 2Q Beat Boosted By Pharma Business -- Market Talk

DJ

Lesen

6. Aug. 2024, 08:20 UTC

Market Talk
Ergebnisse

Bayer's 2Q Results Are a Mixed Bag -- Market Talk

DJ

Lesen

6. Aug. 2024, 06:57 UTC

Market Talk
Ergebnisse

Bayer 2Q Results Could Lead to Muted Share Price Response -- Market Talk

DJ

Lesen

6. Aug. 2024, 05:34 UTC

Ergebnisse

Bayer Saw 2024 Core EPS Between EUR5.10 and EUR5.50

DJ

Lesen

6. Aug. 2024, 05:34 UTC

Ergebnisse

Bayer Saw 2024 Ebitda Before Special Between EUR10.7B and EUR11.3B

DJ

Lesen

6. Aug. 2024, 05:33 UTC

Ergebnisse

Bayer Backs 2024 View

DJ

Lesen

6. Aug. 2024, 05:33 UTC

Ergebnisse

Analysts Saw Bayer 2Q Ebitda Before Special Items at EUR2.08B

DJ

Lesen

6. Aug. 2024, 05:33 UTC

Ergebnisse

Bayer 2Q Ebitda Before Special Items EUR2.11B

DJ

Lesen

6. Aug. 2024, 05:32 UTC

Ergebnisse

Analysts Saw Bayer 2Q Net Pft at EUR70M

DJ

Lesen

6. Aug. 2024, 05:32 UTC

Ergebnisse

Bayer 2Q Net Loss EUR34M

DJ

Lesen

6. Aug. 2024, 05:31 UTC

Ergebnisse

Analysts Saw Bayer 2Q Core EPS at EUR0.84

DJ

Lesen

6. Aug. 2024, 05:31 UTC

Ergebnisse

Bayer 2Q Core EPS EUR0.94

DJ

Lesen

6. Aug. 2024, 05:31 UTC

Ergebnisse

Bayer 2Q EBIT EUR525M

DJ

Lesen

6. Aug. 2024, 05:30 UTC

Ergebnisse

Analysts Saw Bayer 2Q Rev at EUR10.82B

DJ

Lesen

6. Aug. 2024, 05:30 UTC

Ergebnisse

Bayer 2Q Rev EUR11.14B

DJ

Lesen

12. Juli 2024, 07:05 UTC

Market Talk

Bayer's Cost-Savings and Cash Delivery Key Focus for 2Q -- Market Talk

DJ

Lesen

5. Juni 2024, 09:57 UTC

Heiße Aktien

Stocks to Watch Wednesday: CrowdStrike, HPE, Dollar Tree -- WSJ

DJ

Lesen

14. Mai 2024, 11:00 UTC

Market Talk
Ergebnisse

Bayer Earnings Show Progression on Turnaround Strategy -- Market Talk

DJ

Lesen

Peer-Vergleich

Kursveränderung

Bayer AG Prognose

Kursziel

By TipRanks

13.97% Vorteil

12-Monats-Prognose

Durchschnitt 30.11 EUR  13.97%

Hoch 34 EUR

Tief 26 EUR

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Bayer AG – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

11 ratings

1

Buy

10

Halten

0

Sell

Basierend auf 11 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Bayer AG – Dist abgegeben haben.

Technischer Score

By Trading Central

26.13 / 26.685Unterstützung & Widerstand

Kurzfristig

Very Strong Bearish Evidence

Bearish events outweigh bullish events.

Mittelfristig

Weak Bearish Evidence

Recent bearish events outweigh bullish events.

Langfristig

Bearish Evidence

Recent bearish events outweigh bullish events.

Stimmung

By Acuity

128 / 461 Ranking in Finanzen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

EBITDA

Betriebsergebnis

$

Über Bayer AG

Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The company is focusing on their oncology platform o Targeted Alpha Therapies for treating prostate cancer. Th Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and non

Andere Aktien aus dem Sektor

MC

LVMH Moet Hennessy Louis Vuitton SE.

609.7

↑ +1.84%

ALV

Allianz SE

302.5

↑ +0.27%

SAF

Safran SA.

214.4

↑ +2.49%

BBVA

Banco Bilbao Vizcaya Argentaria SA

9.088

↓-2.36%

BN

Danone SA

65.16

↓-0.24%